We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$49.9B
AUM Growth
+$3.67B
Cap. Flow
+$2.03B
Cap. Flow %
4.06%
Top 10 Hldgs %
18.48%
Holding
3,585
New
248
Increased
1,827
Reduced
1,181
Closed
188

Sector Composition

Rank Sector Weight
1 Technology 9.37%
2 Financials 8.94%
3 Healthcare 8.86%
4 Industrials 6.89%
5 Communication Services 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSTM icon
2826
Verastem
VSTM
$610M
$275K ﹤0.01%
4,867
+3,813
+362% +$180K
ESE icon
2827
ESCO Technologies
ESE
$7.92B
$274K ﹤0.01%
4,564
-370
-7% -$21.4K
FT
2828
Franklin Universal Trust
FT
$197M
$274K ﹤0.01%
37,640
+3,111
+9% +$22.5K
MTW icon
2829
Manitowoc
MTW
$675M
$274K ﹤0.01%
7,622
+1,100
+17% +$32K
VICR icon
2830
Vicor
VICR
$10.2B
$274K ﹤0.01%
11,629
CHDN icon
2831
Churchill Downs
CHDN
$6.12B
$273K ﹤0.01%
7,938
+456
+6% +$14.6K
TCON
2832
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$273K ﹤0.01%
434
+88
+25% +$45.8K
SITE icon
2833
SiteOne Landscape Supply
SITE
$4.53B
$272K ﹤0.01%
4,684
-154
-3% -$8.06K
HYB
2834
DELISTED
New America High Income Fund, Inc.
HYB
$272K ﹤0.01%
27,328
+9,000
+49% +$86.8K
Z icon
2835
Zillow
Z
$7.56B
$271K ﹤0.01%
6,730
-340
-5% -$14.4K
CSTM icon
2836
Constellium
CSTM
$3.99B
$270K ﹤0.01%
26,306
-25,275
-49% -$239K
GNL icon
2837
Global Net Lease
GNL
$1.95B
$269K ﹤0.01%
+12,310
New +$267K
NNY icon
2838
Nuveen New York Municipal Value Fund
NNY
$157M
$269K ﹤0.01%
26,329
+335
+1% +$3.41K
PK icon
2839
Park Hotels & Resorts
PK
$2.97B
$269K ﹤0.01%
9,749
-3,192
-25% -$85.4K
RCS
2840
PIMCO Strategic Income Fund
RCS
$250M
$269K ﹤0.01%
+27,622
New +$278K
TEX icon
2841
Terex
TEX
$7.74B
$269K ﹤0.01%
5,967
-1,401
-19% -$55.4K
SO icon
2842
PUT
Southern Company
SO
$107B
$268K ﹤0.01%
162,000
WLK icon
2843
Westlake Corp
WLK
$9.9B
$268K ﹤0.01%
+3,220
New +$237K
CSLT
2844
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$268K ﹤0.01%
62,400
-18,300
-23% -$75.4K
COHU icon
2845
Cohu
COHU
$2.5B
$266K ﹤0.01%
+11,150
New +$211K
THC icon
2846
Tenet Healthcare
THC
$21.1B
$265K ﹤0.01%
16,138
+5,073
+46% +$86K
HMN icon
2847
Horace Mann Educators
HMN
$2.11B
$263K ﹤0.01%
+6,695
New +$247K
CWT icon
2848
California Water Service
CWT
$3.12B
$262K ﹤0.01%
6,864
-878
-11% -$33.2K
AFT
2849
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
$262K ﹤0.01%
15,621
+9
+0.1% +$151
SHLX
2850
DELISTED
Shell Midstream Partners, L.P.
SHLX
$262K ﹤0.01%
9,428
-649
-6% -$18.2K

Similar funds

Raymond James & Associates's Q3 2017 Portfolio in Review

As of Q3 2017, Raymond James & Associates held 3,585 positions worth $49.9B, up 7.9% from $46.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.03B of net new capital in Q3 2017, opening 248 new positions and adding to 1,827 existing holdings. Its largest new stake was PIMCO 15+ Year US TIPS Index Exchange-Traded Fund: 126,820 shares worth $8.41M.

By sector, the portfolio is most concentrated in Technology at 9.4% of assets, up from 9.3% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was McDonald's, an estimated $61.8M trimmed.

  • Raymond James & Associates's largest Q3 2017 buy was PIMCO 15+ Year US TIPS Index Exchange-Traded Fund: 126,820 shares worth $8.41M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q3 2017, an estimated $261M increase.
  • Raymond James & Associates's biggest Q3 2017 reduction was McDonald's, cutting an estimated $61.8M.
  • Raymond James & Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $69.8M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $49.9B portfolio in Q3 2017.
  • Raymond James & Associates opened 248 new positions and closed 188 in Q3 2017.
  • Raymond James & Associates's portfolio value rose 7.9% quarter-over-quarter to $49.9B.

Based on Raymond James & Associates's 13F filing for Q3 2017, filed 13 Nov 2017.